Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Pulmatrix, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 14 | 16 | +2 |
| Shares | 539.8K | 1.49M | +951.3K (+176.2%) |
| Value | $3.69M | $2.71M | −$973.0K (−26.4%) |
New holders (4)
Institutions that held Pulmatrix, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 30,628 | $141.0K | 0.00% |
| Parallax Volatility Advisers, L.P. | 904,896 | $22.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,810 | $13.0K | 0.00% |
| Advisor Group Holdings, Inc. | 101 | $0 | 0.00% |
Sold out (2)
Institutions that held Pulmatrix, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citigroup Inc | 1,000 | $7.00K |
| FMR LLC | 6 | $0 |